Cryptococcus therapy (MCP Hahnemann Uni)

N/A

Report date: 2025/03/19 20:00:56

NME

Base Information

Drug NameCryptococcus therapy (MCP Hahnemann Uni)

Drug Alias NameCryptococcus neoformans therapy (Allegheny)Cryptococcus neoformans therapy (MCP Hahnemann Uni)Cryptococcus therapy (Allegheny)fenbendazole

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsCryptococcosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMCP Hahnemann University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMCP Hahnemann University

Active IndicationsN/A

Inactive IndicationsCryptococcosis

Other Information

ATC CodeN/A